跳至主要内容
临床试验/JPRN-UMIN000037722
JPRN-UMIN000037722招募中未知

Safety and antihypertensive effect of switching from eplerenone to esaxerenone in hypertensive patients. - Safety and antihypertensive effect of switching from eplerenone to esaxerenone in hypertensive patients.

Tokyo Women's Medical University0 个研究点目标入组 200 人开始时间: 2019年8月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with heart failure. Patients who have taken potassium-sparing diuretics (spironolactone, triamterene, and potassium canrenoate) or potassium preparations during the last 8 weeks. Patients whose serum potassium level exceeded 5.0 mEq/L. Patients with severe renal dysfunction (eGFR <30 mL/min/1.73m2).

研究者

发起方
Tokyo Women&#39;s Medical University

相似试验